Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Mol Neurobiol. 2019 May 19;56(11):7719–7730. doi: 10.1007/s12035-019-1637-8

Table 1.

Biological Activity of Cannabinoids

No Compound Oxytosis
(EC50)
Energy
Loss
(EC50)
AβToxicity
(EC50)
Trophic
Withdrawal
(EC50)
Inflammation
(EC50)
1 9ΔTHCA 8 μM 20 μM - - >10 μM
2 CBDA >10 μM 500 nM 70 nM 120 nM >10 μM
3 CBGA - - - - 9 μM
4 9ΔTHC 550 nM 500 nM 100 nM 430 nM 7 μM
5 DMCBD - - >1 μM >5 μM 9 μM
6 CBDV 1.1 μM 90 nM 100 nM 350 nM >10 μM
7 8ΔTHC 400 nM 60 nM 85 nM 275 nM >10 μM
8 CBG 1.9 μM 2 μM 80 nM >1.5 μM >10 μM
9 CBC 750 nM 750 nM 100 nM 200 nM >10 μM
10 CBN 700 nM 300 nM 90 nM 120 nM >10 μM
11 CBD 610 nM 200 nM 30 nM 75 nM 10 μM

EC50 = 50% of maximal protection; Oxytosis and Energy Loss use HT22 cells; Aβ Toxicity uses MC65 cells; Trophic Withdrawal uses primary neurons; Inflammation uses BV2 microglia. THCA, tetrahydrocannabinol acid; CBDA, cannabidiolic acid; CBGA, cannabigerolic acid; Δ9THC; CBD, cannabidiol; CBDV, cannabidivarin, Δ8THC; CBG, cannabigerol; CBC, cannabichromene; CBN, cannabinol; DMCBD, dimethyl cannabidiol. Toxicity at 10 μM is indicated by -. EC50s below 1 μM are shaded in grey.